{
     "PMID": "7968212",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19941201",
     "LR": "20151119",
     "IS": "0024-3205 (Print) 0024-3205 (Linking)",
     "VI": "55",
     "IP": "19",
     "DP": "1994",
     "TI": "A potential 5-HT1A receptor antagonist: p-MPPI.",
     "PG": "1459-62",
     "AB": "A potential 5-HT1A receptor antagonist, p-MPPI, 4-(2'-methoxy-)phenyl-1-[2'-(n-2\"-pyridinyl)-p-iodobenzamido-]ethy l- piperazine, was developed. The [125I]p-MPPI demonstrated high affinity and selectivity toward 5-HT1A receptors; Kd = 0.36 nM and Bmax = 264 fmol/mg of protein in rat hippocampal membrane homogenates. The binding is not sensitive to GTP (300 microM) or Gpp(NH)p (100 microM). In forskolin-stimulated adenylyl cyclase assay using rat hippocampus, p-MPPI (up to 10 microM) showed no agonist activity as compared to that of (+/-)-8-OH-DPAT. At 100 nM it completely antagonized the inhibition of forskolin-stimulated adenylyl cyclase activity produced by 100 nM of (+/-)-8-OH-DPAT. This potential 5-HT1A antagonist may provide a powerful tool for studies of the pharmacology of the 5-HT1A receptor system.",
     "FAU": [
          "Kung, H F",
          "Kung, M P",
          "Clarke, W",
          "Maayani, S",
          "Zhuang, Z P"
     ],
     "AU": [
          "Kung HF",
          "Kung MP",
          "Clarke W",
          "Maayani S",
          "Zhuang ZP"
     ],
     "AD": "Department of Radiology, University of Pennsylvania, Philadelphia 19104.",
     "LA": [
          "eng"
     ],
     "GR": [
          "GM-34852/GM/NIGMS NIH HHS/United States",
          "MH-48125/MH/NIMH NIH HHS/United States",
          "NS-24538/NS/NINDS NIH HHS/United States",
          "etc."
     ],
     "PT": [
          "Journal Article",
          "Research Support, U.S. Gov't, P.H.S."
     ],
     "PL": "Netherlands",
     "TA": "Life Sci",
     "JT": "Life sciences",
     "JID": "0375521",
     "RN": [
          "0 (Aminopyridines)",
          "0 (Iodine Radioisotopes)",
          "0 (Ligands)",
          "0 (Piperazines)",
          "0 (Receptors, Serotonin)",
          "0 (Serotonin Antagonists)",
          "155204-23-2",
          "(4-(2'-methoxyphenyl)-1-(2'-(N-(2''-pyridinyl)-4-iodobenzamido)ethyl)piperazine)",
          "1F7A44V6OU (Colforsin)",
          "86-01-1 (Guanosine Triphosphate)",
          "EC 4.6.1.1 (Adenylyl Cyclases)"
     ],
     "SB": "IM",
     "MH": [
          "Adenylyl Cyclases/drug effects/metabolism",
          "Aminopyridines/*metabolism/*pharmacology",
          "Animals",
          "Binding, Competitive",
          "Colforsin/pharmacology",
          "Guanosine Triphosphate/pharmacology",
          "Hippocampus/drug effects/metabolism/ultrastructure",
          "In Vitro Techniques",
          "Iodine Radioisotopes",
          "Kinetics",
          "Ligands",
          "Piperazines/*metabolism/*pharmacology",
          "Rats",
          "Receptors, Serotonin/*metabolism",
          "Serotonin Antagonists/*pharmacology",
          "Stimulation, Chemical"
     ],
     "EDAT": "1994/01/01 00:00",
     "MHDA": "1994/01/01 00:01",
     "CRDT": [
          "1994/01/01 00:00"
     ],
     "PHST": [
          "1994/01/01 00:00 [pubmed]",
          "1994/01/01 00:01 [medline]",
          "1994/01/01 00:00 [entrez]"
     ],
     "PST": "ppublish",
     "SO": "Life Sci. 1994;55(19):1459-62.",
     "term": "hippocampus"
}